EPIRIUM

Epirium Bio is a clinical stage biopharmaceutical company that has uncovered unique insights into the biology of mitochondrial biogenesis and function, leading to an advanced understanding of its pleotropic clinical effect in disease.These findings have led to the discovery of a novel, previously undescribed pharmacological approach to the treatment of diseases characterized by deficits in these pathways. They have identified and established an IP-protected platform of small molecules that const... itute a new class of therapeutics with the potential to stimulate mitochondrial biogenesis and function. They are currently developing their lead clinical candidate, which has been shown to trigger mitochondrial biogenesis in early human studies, as a potential treatment across a number of therapeutic areas, starting with rare diseases.More